64.04 0.00 (0.00%)
After hours: 7:49PM EDT
|Bid||64.04 x 1300|
|Ask||64.15 x 800|
|Day's Range||63.55 - 66.00|
|52 Week Range||20.08 - 74.81|
|Beta (3Y Monthly)||-0.06|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 29, 2019 - Aug 2, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||80.00|
Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM): Tandem Diabetes Care, Inc., a medical device company, designs, develops...
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the BMO 2019 Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 in New York at 1:20pm Eastern Time .
NEW YORK , June 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...
Fourth paragraph, fourth sentence of release dated June 9, 2019, should read: Time spent below 70 mg/dL was 1.4 percent with Control-IQ technology compared to 1.9 percent in the control group (p
Tandem Diabetes Care (TNDM) plans to file an application seeking FDA approval for use of its Control-IQ technology in t: slim X2 insulin pumps for patients aged 14 and above.
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?(Continued from Prior Part)First automated insulin delivery pumpTandem Diabetes Care’s (TNDM) automated insulin delivery system, t: slim X2 Insulin Pump with Basal-IQ technology,
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?(Continued from Prior Part)Tandem Diabetes Care’s pump demandIn the first quarter, Tandem Diabetes Care (TNDM) shipped 14,700 insulin pumps, a YoY rise of 232%. The demand rose
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?(Continued from Prior Part)Tandem Diabetes Care’s revenue trajectoryIn its first-quarter earnings conference call, Tandem Diabetes Care (TNDM) increased its fiscal 2019 revenue
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?Evolving insulin delivery landscapeUntil the start of 2017, the insulin pump technology space was mainly dominated by big companies such as Medtronic (MDT) and Johnson & Johnson
Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology. The t:slim X2 insulin pump with Control-IQ technology utilizes Dexcom G6 continuous glucose monitoring (CGM) sensor values to predict glucose levels and adjust insulin delivery to prevent highs and lows, while still allowing the user to manually bolus for meals.
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time following data presentations at the 79th Scientific Sessions of the American Diabetes Association on its t:slim X2 with Control-IQ technology system.
Tandem Diabetes (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tandem Diabetes is the IBD Stock Of The Day after the medical device company knocked its first-quarter results out of the park this month. Now, Tandem stock is approaching a breakout.
While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the followin
Sometimes the U.S. stock market sends a clear, unambiguous message. The message the stock market sent during Federal Reserve Chairman Jerome Powell’s press conference Wednesday says that the market is vulnerable. • The chart shows that the stock market rose immediately after the Fed decision was announced.
Tandem's (TNDM) introduction of t:slim X2 with Basal-IQ technology, ramped-up supply capacity along with its global launch, substantially drive its top line in Q1.